News for April 2022

News Archive

Thirona’s RetCAD™ and iCare are joining forces in Europe to offer an integral solution for eye screening with artificial intelligence. Thirona’s RetCAD™ and iCare are joining forces in Europe to offer an integral solution for eye screening with artificial intelligence.

Nijmegen, the Netherlands April 27th, 2022 – Thirona, one of the leading companies specializing in artificial intelligence for medical image analysis, has signed a strategic partnership agreement with iCare, for the implementation of Thirona’s RetCAD™ artificial intelligence software into the iCare solutions for eye disease screening, in Europe. The partnership underpins both companies’ technological leadership in this field.

Proofig launches first commercial automated image duplication and manipulation detection software for scientific publications Proofig launches first commercial automated image duplication and manipulation detection software for scientific publications

To provide publishers, universities and scientific researchers with a tool to check image integrity before submission, Dr. Dror Kolodkin-Gal, founder of Proofig, have launched an automated image integrity detection software. This automated artificial intelligence (AI) tool detects the majority of forms of image duplication and some of the manipulation. Publishers and researchers can use the tool to accurately check images before submission, reducing the risk of post publication retraction.

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus’ VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus’

April 7, 2022, VectorBuilder Inc. – a global leader in gene delivery solutions – has announced the construction of a new R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will significantly expand VectorBuilder’s R&D capabilities and its production capacity for both research-use and cGMP-grade gene delivery vectors, allowing the company to continue supporting groundbreaking research worldwide.

Kent-Based Discovery Park is the First Science and Innovation Park to Join Industrial Biotechnology Innovation Centre Kent-Based Discovery Park is the First Science and Innovation Park to Join Industrial Biotechnology Innovation Centre

Discovery Park, based at Sandwich in Kent, has become the first Life Science and Innovation Campus to join the Industrial Biotechnology Innovation Centre (IBioIC), further cementing its ambition to become a centre of excellence.

Novel Drug from Neuro-Bio Effective in a Mouse Model of Alzheimer’s Disease Nbp14 Targets Possible Primary Driver of Neurodegeneration Novel Drug from Neuro-Bio Effective in a Mouse Model of Alzheimer’s Disease Nbp14 Targets Possible Primary Driver of Neurodegeneration

Neuro-Bio Ltd, finds its new drug candidate effectively treats neurodegeneration in a mouse model of Alzheimer’s disease.

B or not to B: Insights in the regulation of anti-viral immunity B or not to B: Insights in the regulation of anti-viral immunity

Researchers delve into the inner workings of the antibody immune response, finding key differences in the metabolism of two closely related immune cell subsets.